Galactosylated chitosan-graft-poly(ethylene glycol) as hepatocyte-targeting DNA carrier

Journal of Controlled Release

Volumn 76, Issue 3, 2001, Pages 349-362

  Park, I K ^a   Kim, T H ^a   Park, Y H ^a   Shin, B A ^b   Choi, E S ^b   Chowdhury, E H ^c   Akaike, T ^c   Cho, C S ^a  

^a Seoul National University   (South Korea)

^b Chonnam National University Medical School   (South Korea)

^c TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Asialoglycoprotein receptors; DNA carrier; Galactosylated chitosan; Hepatocyte targeting; PEG

Indexed keywords

ASIALOGLYCOPROTEIN RECEPTOR; CHITOSAN; DNA; GALACTOSE; LACTOBIONIC ACID; LIGAND; MACROGOL;

AGAR GEL ELECTROPHORESIS; ARTICLE; CELL MEMBRANE PERMEABILITY; CHEMICAL STRUCTURE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; DNA CONFORMATION; DNA DRUG COMPLEX; DRUG PENETRATION; DRUG SPECIFICITY; DRUG STABILITY; GENE TARGETING; GENETIC TRANSFECTION; LIVER CELL; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN INTERACTION;

CHITIN; CHITOSAN; DNA; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EXCIPIENTS; HELA CELLS; HEPATOCYTES; HUMANS; NEPHELOMETRY AND TURBIDIMETRY; POLYETHYLENE GLYCOLS; TRANSFECTION;

EID: 0035914230     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(01)00448-5     Document Type: Article

References (33)

1. An in vivo model of somatic-cell gene-therapy for human severe combined immunodeficiency
2. Correction of the ion-transport defect in cystic-fibrosis trasgenic mice by gene-therapy
3. Expression of the human cystic-fibrosis transmembrane conductance regulator gene in the mouse lung after in vivo intratracheal plasmid-mediated gene-transfer
4. Efficient expression of retroviral vector-transduced human low-density lipoprotein (LDL) receptor in LDL receptor-deficient rabbit fibroblasts in vitro
5. Gene therapy in the United States: A five-year status report
6. Adenovirus-mediated transfer of a recombinant alpha-L antitrypsin gene to the lung epithelium in vivo
7. Gene-transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection
8. Safety considerations in somatic gene therapy of human disease with retrovirus vectors
9. DNA complexes with polycations for the delivery of genetic material into cells
10. Peptide-mediated release of folate-targeted liposome contents from endosomal compartments
11. Lipofection - A highly efficient, lipid-mediated DNA-transfection procedure
12. Application of membrane-based dendrimer/DNA complexes for solid phase transfection in vitro and in vivo
13. Poly(L-lysine) has different membrane transport and drug-carrier properties when complexed with heparin
14. Polylysine-drug conjugates
15. Carbamylation decreases the cytotoxicity but not the drug-carrier properties of polylysines
16. Application of Chitin and Chitosan for biomaterial
17. Use of Chitosan as a biomaterial - Studies on its safety and hemostatic potential
18. Galactosylated chitosan-graft-dextran as hepatocyte-targeting DNA carrier
19. Polyethylene glycol enhances lipoplex-cell associated and lipofection
20. Cancer therapy with chemically modified enzymes. I. Antitumor properties of polyethylene glycol-asparaginase conjugates
21. Molecular design of hybrid tumor-necrosis-factor-alpha with polyethylene-glycol increases its antitumor potency
22. Lactose-poly(ethylene glycol)-grafted poly-L-lysine as hepatoma cell-targeted gene carrier
23. A novel growth-inducible gene that encodes a protein with a conserved cold-shock domain
24. Long-circulating (sterically stabilized) liposomes for targeted drug-delivery
25. Nonviral vectors for in-vivo gene delivery - Physiochemical and pharmacokinetic considerations
26. Intratumoral pharmacokinetics and in-vivo gene-expression of naked plasmid DNA and its cationic liposome complexes after direct gene-transfer
27. A new non-viral DNA delivery vector: The terplex system
28. Passive tumor targeting of soluble macromolecules and drug conjugates
29. Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery
30. PEGylated DNA/transferrin-PEI complexes: Reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery
31. Enhancement of transfection efficiency using ligand-modified lipid vesicles